PHILLIP STURGEON, M.D.; EUGENE P. ADASHEK, M.D.; JAMES L. SELF, M.D.; E. RICHARD STIEHM, M.D.; GARSON H. TISHKOFF, M.D.
Blood transfusion therapy offers the special hazard of isoimmunization, possibly on first exposure and with increasing likelihood on subsequent exposures. In addition, contaminants such as viruses and unneeded components can present serious problems. The treatment of coagulation deficiencies has made great advances, but problems are still substantial. The gamma globulins have become increasingly significant in the prevention and treatment of certain illnesses. There is great need for both increased accuracy in crossmatching and for more efficient use of specific components.
STURGEON P, ADASHEK EP, SELF JL, STIEHM ER, TISHKOFF GH. Recent Developments in Blood Components Therapy. Ann Intern Med. ;74:113–125. doi: 10.7326/0003-4819-74-1-113
Download citation file:
Published: Ann Intern Med. 1971;74(1):113-125.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use